# Ologen® Collagen Matrix Versus Mitomycin-C in Patients With Juvenile-onset Open Angle Glaucoma

> **NCT03548805** · NA · COMPLETED · sponsor: **L.V. Prasad Eye Institute** · enrollment: 30 (actual)

## Conditions studied

- Open Angle Glaucoma

## Interventions

- **PROCEDURE:** ologen® Collagen Matrix
- **PROCEDURE:** Trabeculectomy with low dose mitomycin C

## Key facts

- **NCT ID:** NCT03548805
- **Lead sponsor:** L.V. Prasad Eye Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-16
- **Primary completion:** 2023-04-01
- **Final completion:** 2023-05-19
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03548805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03548805, "Ologen® Collagen Matrix Versus Mitomycin-C in Patients With Juvenile-onset Open Angle Glaucoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03548805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*